跳至主要内容
临床试验/NCT05923359
NCT05923359进行中(未招募)不适用

Realtime Diagnosis From Electrocardiogram Artificial Intelligence-Guided Screening for Atrial Fibrillation With Long Follow-Up (REGAL)

Mayo Clinic2 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2024年4月10日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
Mayo Clinic
入组人数
2,000
试验地点
2
主要终点
Atrial fibrillation

研究概览

简要总结

The purpose of this research is to test whether Apple Watch, used as a long-term monitoring device, can enable early detection of atrial fibrillation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Had a 10-second 12-lead ECG done at Mayo Clinic
  • Have a high AI-ECG risk score indicating a high likelihood of previously unrecognized AF
  • Men with CHA2DS2-VASc2 ≥2 or women with CHA2DS2-VASc ≥ 3

排除标准

  • Diagnosed atrial fibrillation
  • Diagnosed dementia
  • Diagnosed end-stage kidney disease
  • History of intracranial bleeding
  • Have an implantable cardiac monitoring device, including a pacemaker, a defibrillator, or implanted loop recorder
  • Missing date of birth
  • Residence outside of the U.S. or missing address information

结局指标

主要结局

Atrial fibrillation

时间窗: 2 years

Number of participants diagnosed with atrial fibrillation

次要结局

  • Ischemic stroke or systemic embolism events(2 years)
  • Major bleeding(2 years)
  • Change in individuals' maximum learning span(Baseline, 2 years)
  • Change in processing speed measure(Baseline, 2 years)
  • Mortality(2 years)

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiaoxi Yao

Principal Investigator

Mayo Clinic

研究点 (2)

Loading locations...

相似试验